Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Helix BioPharma Max Drawdown (5Y): 88.01% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 88.01% |
February 29, 2024 | 87.69% |
January 31, 2024 | 87.42% |
December 31, 2023 | 87.42% |
November 30, 2023 | 87.42% |
October 31, 2023 | 87.42% |
September 30, 2023 | 87.42% |
August 31, 2023 | 87.42% |
July 31, 2023 | 87.42% |
June 30, 2023 | 87.42% |
May 31, 2023 | 87.42% |
April 30, 2023 | 87.42% |
March 31, 2023 | 87.42% |
February 28, 2023 | 87.42% |
January 31, 2023 | 87.42% |
December 31, 2022 | 87.42% |
November 30, 2022 | 87.42% |
October 31, 2022 | 87.42% |
September 30, 2022 | 87.42% |
August 31, 2022 | 87.42% |
July 31, 2022 | 87.42% |
June 30, 2022 | 87.42% |
May 31, 2022 | 87.42% |
April 30, 2022 | 87.42% |
March 31, 2022 | 87.42% |
Date | Value |
---|---|
February 28, 2022 | 87.42% |
January 31, 2022 | 87.42% |
December 31, 2021 | 87.42% |
November 30, 2021 | 87.42% |
October 31, 2021 | 87.42% |
September 30, 2021 | 87.42% |
August 31, 2021 | 87.42% |
July 31, 2021 | 87.42% |
June 30, 2021 | 87.42% |
May 31, 2021 | 87.42% |
April 30, 2021 | 87.42% |
March 31, 2021 | 87.42% |
February 28, 2021 | 87.42% |
January 31, 2021 | 87.42% |
December 31, 2020 | 87.42% |
November 30, 2020 | 87.42% |
October 31, 2020 | 87.42% |
September 30, 2020 | 87.42% |
August 31, 2020 | 87.42% |
July 31, 2020 | 87.42% |
June 30, 2020 | 87.42% |
May 31, 2020 | 87.42% |
April 30, 2020 | 87.42% |
March 31, 2020 | 87.42% |
February 29, 2020 | 87.42% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
87.42%
Minimum
Apr 2019
88.01%
Maximum
Mar 2024
87.44%
Average
87.42%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.60% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -18.68 |
Beta (5Y) | -0.1129 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.6% |
Historical Sharpe Ratio (5Y) | -0.2003 |
Historical Sortino (5Y) | -0.5114 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.64% |